Shotaro Shimada

Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Norimichi Hattori, Yukiko Kawaguchi, Yohei Sasaki et al. · Biology of Blood and Marrow Transplantation · 2019 · 41 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, T-regulatory Cell +18

Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome

Norimichi Hattori, Bungo Saito, Yohei Sasaki et al. · Biology of Blood and Marrow Transplantation · 2018 · 37 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +15

Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome

Yuta Baba, Bungo Saito, Shotaro Shimada et al. · Leukemia Research · 2018 · 23 citations · Full text

Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation

Shun Fujiwara, Norimichi Hattori, Tomoharu Matsui et al. · Transplantation Proceedings · 2019 · 11 citations

Genetic Epidemiology, Pathology, Cell Replacement Therapy +16

Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults

Norimichi Hattori, Bungo Saito, Tomoharu Matsui et al. · Biology of Blood and Marrow Transplantation · 2019 · 10 citations · Full text